A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial

NCT05670470 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Bowel Preparation

Interventions

DRUG: CTP0303
DRUG: Orafang Tab

Sponsor

Taejoon Pharmaceutical Co., Ltd.